Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 23 Dec 2024 for BioSyent Inc., €846k.
Filing timeline
BuySaleFAX Capital Corp.
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
FAX Capital Corp.: trading record in brief
FAX Capital Corp. is a declared insider of BioSyent Inc., with filings sourced from SEDI. Between 13 April 2023 and 23 December 2024, the trades on record add up to 6 filings.
Sales make up the whole of the open-market record (6 sales, €6.5M). Since January 2024: no purchases and 6 sales on the market.
On 23 December 2024 came the latest disclosure, an open-market sale for €846k in BioSyent Inc. The median gap between a trade and its publication by SEDI is 11 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to FAX Capital Corp.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
112,400 shares@ CA$11.2772Common SharesTSXSEDI:4423679
27,500 shares@ CA$11.1015100.0% of flowCommon SharesTSXSEDI:4412194
65,000 shares@ CA$7.706.0% of flowCommon SharesTSXSEDI:4407420
4,700 shares@ CA$11.2420.6% of flowCommon SharesTSXSEDI:4407106
230,800 shares@ CA$11.1230.8% of flowCommon SharesTSXSEDI:4407107
500,000 shares@ CA$10.05Common SharesTSXSEDI:4369250
6 of 6 declarations
